These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 913330)

  • 1. beta-Endorphin secretion of arginine vasopressin in vivo.
    Weitzman RE; Fisher DA; Minick S; Ling N; Guillemin R
    Endocrinology; 1977 Nov; 101(5):1643-6. PubMed ID: 913330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stimulatory effect of a non-opiate beta-endorphin fragment on arginine-vasopressin release in rats.
    Laczi F; Sykes JE; Wiegant VM; de Wied D
    Acta Med Hung; 1984; 41(1):55-63. PubMed ID: 6330664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the opioid peptide beta-endorphin on the in vivo release of vasopressin in rats under various conditions.
    ten Haaf JA; van Wimersma Greidanus TB; Maigret C; De Wied D
    Neuroendocrinology; 1986; 44(1):102-7. PubMed ID: 2946974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
    Koenig JI; Meltzer HY; Devane GD; Gudelsky GA
    Endocrinology; 1986 Jun; 118(6):2534-9. PubMed ID: 2938937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat.
    Makara GB; Sutton S; Otto S; Plotsky PM
    Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion.
    Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J
    Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of eicosanoids in release of oxytocin and vasopressin from the neural lobe of the rat pituitary.
    Negro-Vilar A; Snyder GD; Falck JR; Manna S; Chacos N; Capdevila J
    Endocrinology; 1985 Jun; 116(6):2663-8. PubMed ID: 3922746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal patterns of vasopressin release following electrical stimulation of the amygdala and the neuroendocrine pathway in the monkey.
    Hayward JN; Murgas K; Pavasuthipaisit K; Perez-Lopez FR; Sofroniew MV
    Neuroendocrinology; 1977; 23(2):61-75. PubMed ID: 408726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site of ATP and phenylephrine synergistic stimulation of vasopressin release from the hypothalamo-neurohypophyseal system.
    Song Z; Sladek CD
    J Neuroendocrinol; 2006 Apr; 18(4):266-72. PubMed ID: 16503921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro.
    Knepel W; Nutto D; Vlaskovska M; Kittel C
    J Endocrinol; 1985 Aug; 106(2):189-95. PubMed ID: 3160802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in oxytocin and vasopressin secretion during sexual activity in men.
    Murphy MR; Seckl JR; Burton S; Checkley SA; Lightman SL
    J Clin Endocrinol Metab; 1987 Oct; 65(4):738-41. PubMed ID: 3654918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland.
    Larsen PJ; Jukes KE; Chowdrey HS; Lightman SL; Jessop DS
    Endocrinology; 1994 Apr; 134(4):1635-9. PubMed ID: 8137725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
    Knepel W; Meyer DK
    J Physiol; 1983 Aug; 341():507-15. PubMed ID: 6620188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile arginine vasopressin release from the rat hypothalamo neurohypophyseal system during osmotic stimulation.
    Ohno N
    Acta Med Okayama; 1981 Jun; 35(3):205-13. PubMed ID: 6457510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally administered PGE2 inhibits gastric secretion in the rat by releasing vasopressin.
    Puurunen J; Leppäluoto J
    Eur J Pharmacol; 1984 Sep; 104(1-2):145-50. PubMed ID: 6094207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of beta-endorphin in the deteriorating effect of arginine vasopressin on burn shock in rats.
    Sun K; Lin BC; Zhang C; Wang CH; Zhu HN
    Circ Shock; 1989 Nov; 29(3):167-74. PubMed ID: 2591029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine vasopressin enhances periaqueductal gray synthesis and secretion of enkephalin and endorphin in the rat.
    Yang J; Yang Y; Xu HT; Chen JM; Liu WY; Lin BC
    Brain Res Bull; 2006 Dec; 71(1-3):193-9. PubMed ID: 17113946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone stimulates release of arginine vasopressin and oxytocin in vivo.
    Weitzman RE; Firemark HM; Glatz TH; Fisher DA
    Endocrinology; 1979 Apr; 104(4):904-7. PubMed ID: 108088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
    Vlaskovska M; Hertting G; Knepel W
    Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.